GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Piotroski F-Score

Lipum AB (OSTO:LIPUM) Piotroski F-Score : 2 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lipum AB Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lipum AB has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Lipum AB's Piotroski F-Score or its related term are showing as below:

OSTO:LIPUM' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 2   Max: 2
Current: 2

During the past 5 years, the highest Piotroski F-Score of Lipum AB was 2. The lowest was 2. And the median was 2.


Lipum AB Piotroski F-Score Historical Data

The historical data trend for Lipum AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipum AB Piotroski F-Score Chart

Lipum AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A N/A 2.00 2.00

Lipum AB Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 2.00 N/A 1.00 2.00

Competitive Comparison of Lipum AB's Piotroski F-Score

For the Biotechnology subindustry, Lipum AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipum AB's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipum AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Lipum AB's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Sep22) TTM:
Net Income was -13.017 + -7.173 + 0 + -9.451 = kr-29.64 Mil.
Cash Flow from Operations was -14.734 + -6.071 + 0 + -7.295 = kr-28.10 Mil.
Revenue was 0 + 0 + 0 + 0 = kr0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = kr0.00 Mil.
Average Total Assets from the begining of this year (Sep22)
to the end of this year (Dec23) was
(12.548 + 34.551 + 28.268 + 18.785 + 12.11) / 5 = kr21.2524 Mil.
Total Assets at the begining of this year (Sep22) was kr12.55 Mil.
Long-Term Debt & Capital Lease Obligation was kr1.76 Mil.
Total Current Assets was kr11.91 Mil.
Total Current Liabilities was kr5.78 Mil.
Net Income was -29.176 + -5.83 + -9.337 + -9.901 = kr-54.24 Mil.

Revenue was 0 + 0 + 0 + 0 = kr0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = kr0.00 Mil.
Average Total Assets from the begining of last year (Sep21)
to the end of last year (Sep22) was
(62.471 + 49.662 + 31.015 + 22.906 + 12.548) / 5 = kr35.7204 Mil.
Total Assets at the begining of last year (Sep21) was kr62.47 Mil.
Long-Term Debt & Capital Lease Obligation was kr1.57 Mil.
Total Current Assets was kr10.56 Mil.
Total Current Liabilities was kr6.07 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lipum AB's current Net Income (TTM) was -29.64. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lipum AB's current Cash Flow from Operations (TTM) was -28.10. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep22)
=-29.641/12.548
=-2.36220912

ROA (Last Year)=Net Income/Total Assets (Sep21)
=-54.244/62.471
=-0.86830689

Lipum AB's return on assets of this year was -2.36220912. Lipum AB's return on assets of last year was -0.86830689. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Lipum AB's current Net Income (TTM) was -29.64. Lipum AB's current Cash Flow from Operations (TTM) was -28.10. ==> -28.10 > -29.64 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Dec23
=1.761/21.2524
=0.08286123

Gearing (Last Year: Sep22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep21 to Sep22
=1.566/35.7204
=0.04384049

Lipum AB's gearing of this year was 0.08286123. Lipum AB's gearing of last year was 0.04384049. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=11.913/5.777
=2.06214298

Current Ratio (Last Year: Sep22)=Total Current Assets/Total Current Liabilities
=10.556/6.068
=1.73961767

Lipum AB's current ratio of this year was 2.06214298. Lipum AB's current ratio of last year was 1.73961767. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Lipum AB's number of shares in issue this year was 9.675. Lipum AB's number of shares in issue last year was 5.248. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

Lipum AB's gross margin of this year was . Lipum AB's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep22)
=0/12.548
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep21)
=0/62.471
=0

Lipum AB's asset turnover of this year was 0. Lipum AB's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+1+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lipum AB has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Lipum AB  (OSTO:LIPUM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Lipum AB Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Lipum AB's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipum AB (OSTO:LIPUM) Business Description

Traded in Other Exchanges
N/A
Address
Tvistevagen 48 C, Umea, SWE, 907 36
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.

Lipum AB (OSTO:LIPUM) Headlines

No Headlines